Amgen
Search results
2 days ago · Until today, only one drug, developed by Horizon Therapeutics (now acquired by Amgen), has been approved by the FDA in 2020 for treating adults with thyroid eye disease.
2 days ago · Until today, only one drug, developed by Horizon Therapeutics (now acquired by Amgen), has been approved by the FDA in 2020 for treating adults with thyroid eye disease.
4 days ago · New Jersey man indicates he has been left with permanent hearing impairment from Tepezza, alleging that Horizon Therapeutics failed to instruct doctors about the importance of conducting...
4 days ago · Horizon Therapeutics filed a motion to dismiss a recent Tepezza lawsuit wherein the plaintiff claimed use of this thyroid eye disease medication resulted in permanent hearing loss. Horizon argues that the plaintiff's claims are preempted by federal law as they failed to illustrate that the defendant could have added warnings to the medication's ...
Jun 19, 2024 · Horizon Therapeutics USA, Inc – was directly filed this week in the Tepezza MDL by a Florida man who claims that he suffered serious injuries as the result of the plaintiff’s infusion teprotumumab, the prescription drug marketed as Tepezza.
4 days ago · The biopharmaceutical company earned $945 million during the quarter, compared to the consensus estimate of $873.52 million. Horizon Therapeutics Public had a trailing twelve-month return on equity of 20.46% and a net margin of 12.02%. Horizon Therapeutics Public's quarterly revenue was up 7.8% compared to the same quarter last year.
3 days ago · Amgen is letting go of 350 employees following its $27.8 billion acquisition of Horizon Therapeutics, according to several media reports on Tuesday. The layoffs will affect Horizon roles that overlap with existing teams at Amgen, a company spokesperson told Fierce Pharma .
